Prestigious Award Honors Breakthrough T1D Team Member Dr. Albanese-O’Neill
Congratulations to Dr. Albanese-O'Neill, director of screening and clinical trials, who was honored with the Diabetes Care and Education Specialist…
Study Shows No Link Between T1D Diagnoses and COVID-19
JDRF-funded researchers in Colorado and Germany found no link between COVID-19 and type 1 diabetes in children and adolescents ages…
One Important Step Towards Affordable Insulin
Congress passes the Inflation Reduction Act, which contains provisions that will make insulin affordable for some Americans. Much more must…
A New Tool to Accurately Diagnose Type 1 in Adults
Misdiagnosing adults with type 1 diabetes (T1D) is an all-too-common problem that can have tragic consequences. Breakthrough T1D and IQVIA…
Breakthrough T1D Urges Senate to Support Insulin Affordability Provisions as Part of Inflation Reduction Act of 2022
Breakthrough T1D Urges Senate to Support Insulin Affordability Provisions as Part of Inflation Reduction Act of 2022
Diabetes Research in Pediatrics? The International Society Has Your Back
Learn more about the recipients of the International Society for Pediatrics and Adolescent Diabetes (ISPAD)-Breakthrough T1D Fellowships here!
California to Manufacture Insulin
California Governor Gavin Newsome announced plans for the state to manufacture and distribute its own insulin.
Breakthrough T1D welcomes new Chair and members to Global Mission Board
Longtime volunteer Jennifer Bennett has been appointed Chair of the Breakthrough T1D Global Mission Board, effective July 1, 2022.
Remembering T1D Champion Steve Davis
Steve Davis was a leader in the restaurant and consumer packaged goods industries, but to Breakthrough T1D, he was a…
Breakthrough T1D Timeline: Stem Cell Therapies
Stem cells have the potential to lead to treatments for type 1 diabetes, but it has taken Breakthrough T1D more…
